Analysis of Qa-1b peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes

被引:92
作者
Kraft, JR
Vance, RE
Pohl, J
Martin, AM
Raulet, DH
Jensen, PE
机构
[1] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Microchem Facil, Atlanta, GA 30322 USA
[3] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA
[4] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA
关键词
CD94; NKG2A; Qa-1; natural killer cell; major histocompatibility complex;
D O I
10.1084/jem.192.5.613
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The major histocompatibility complex class Ib protein, Qa-1(b), serves as a ligand for murine CD94/NKG2A natural killer (NK) cell inhibitory receptors. The Qa-1(b) peptide-binding site is predominantly occupied by a single nonameric peptide, Qa-1 determinant modifier (Qdm), derived from the leader sequence of H-2D and L molecules. Five anchor residues were identified in this study by measuring the peptide-binding affinities of substituted Qdm peptides in experiments with purified recombinant Qa-1(b). A candidate peptide-binding motif was determined by sequence analysis of peptides eluted from Qa-1 that had been folded in the presence of random peptide libraries or pools of Qdm derivatives randomized at specific anchor positions. The results indicate that Qa-1(b) can bind a diverse repertoire of peptides but that Qdm has an optimal primary structure for binding Qa-1(b). Flow cytometry experiments with Qa-1(b) tetramers and NK target cell lysis assays demonstrated that CD94/NKG2A discriminates between Qa-1(b) complexes containing peptides with substitutions at nonanchor positions P4, P5, or P8. Our findings suggest that it may be difficult for viruses to generate decoy peptides that mimic Qdm and raise the possibility that competitive replacement of Qdm with other peptides may provide a novel mechanism for activation of NK cells.
引用
收藏
页码:613 / 623
页数:11
相关论文
共 65 条
[1]   REGULATION OF QA-1 EXPRESSION AND DETERMINANT MODIFICATION BY AN H-2D-LINKED GENE, QDM [J].
ALDRICH, CJ ;
RODGERS, JR ;
RICH, RR .
IMMUNOGENETICS, 1988, 28 (05) :334-344
[2]  
ALDRICH CJ, 1992, J IMMUNOL, V149, P3773
[3]   IDENTIFICATION OF A TAP-DEPENDENT LEADER PEPTIDE RECOGNIZED BY ALLOREACTIVE T-CELLS SPECIFIC FOR A CLASS IB ANTIGEN [J].
ALDRICH, CJ ;
DECLOUX, A ;
WOODS, AS ;
COTTER, RJ ;
SOLOSKI, MJ ;
FORMAN, J .
CELL, 1994, 79 (04) :649-658
[4]   Phenotypic analysis of antigen-specific T lymphocytes [J].
Altman, JD ;
Moss, PAH ;
Goulder, PJR ;
Barouch, DH ;
McHeyzerWilliams, MG ;
Bell, JI ;
McMichael, AJ ;
Davis, MM .
SCIENCE, 1996, 274 (5284) :94-96
[5]   Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis [J].
Borrego, F ;
Ulbrecht, M ;
Weiss, EH ;
Coligan, JE ;
Brooks, AG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (05) :813-818
[6]  
Bouwer HGA, 1997, J IMMUNOL, V159, P2795
[7]   The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9 [J].
Braud, V ;
Jones, EY ;
McMichael, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (05) :1164-1169
[8]   TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide [J].
Braud, VM ;
Allan, DSJ ;
Wilson, D ;
McMichael, AJ .
CURRENT BIOLOGY, 1998, 8 (01) :1-10
[9]   HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C [J].
Braud, VM ;
Allan, DSJ ;
O'Callaghan, CA ;
Söderström, K ;
D'Andrea, A ;
Ogg, GS ;
Lazetic, S ;
Young, NT ;
Bell, JI ;
Phillips, JH ;
Lanier, LL ;
McMichael, AJ .
NATURE, 1998, 391 (6669) :795-799
[10]  
Brooks AG, 1999, J IMMUNOL, V162, P305